Digoxin Toxicity and Use of Digoxin Immune Fab
- 1 May 2016
- journal article
- research article
- Published by Elsevier in JACC: Heart Failure
- Vol. 4 (5) , 357-364
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial dataBMJ, 2015
- Relation of Digoxin Use in Atrial Fibrillation and the Risk of All-Cause Mortality in Patients ≥65 Years of Age With Versus Without Heart FailureThe American Journal of Cardiology, 2014
- 2013 ACCF/AHA Guideline for the Management of Heart FailureJACC, 2013
- Digitalis Toxicity: A Fading but Crucial Complication to RecognizeThe American Journal of Medicine, 2012
- Digoxin Associates with Mortality in ESRDJournal of the American Society of Nephrology, 2010
- Digoxin-specific Fab fragments as single first-line therapy in digitalis poisoningCritical Care Medicine, 2008
- Assessment of digoxin antibody use in patients with elevated serum digoxin following chronic or acute exposureIntensive Care Medicine, 2008
- Digoxin Use and Digoxin Toxicity in the Post-DIG Trial EraJournal of Cardiac Failure, 2006
- Association of Serum Digoxin Concentration and Outcomes in Patients With Heart FailureJAMA, 2003
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997